These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23688751)

  • 1. [Efficacy and safety of low-dose rituximab combined with different dosage of glucocorticoids for immune thrombocytopenia].
    Xing WW; Li ZY; Yan ZL; Liu KG; Li N; Cao J; Pan XY; He XP; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):409-12. PubMed ID: 23688751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.
    Li Z; Mou W; Lu G; Cao J; He X; Pan X; Xu K
    Int J Hematol; 2011 Jan; 93(1):91-8. PubMed ID: 21188563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of different therapeutic regimens on regulatory T cells in patients of primary immune thrombocytopenia].
    Li ZY; Li DP; Yan ZL; Xing WW; Liu KG; Cao J; He XP; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):478-81. PubMed ID: 23827100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of two different low-dose rituximab regimens for Chinese adult patients with immune thrombocytopenia].
    Sui T; Zhang L; Zhou ZP; Xue F; Ge J; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):583-6. PubMed ID: 22338149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y; Wang XM; Mao M; Zhang XY; Fu L; Ai HM; Zhang LX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy and safety of low-dose rituximab in treatment of primary Sjögren's syndrome with thrombocytopenia].
    Zhou L; Xin XF; Wu HX
    Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):37-41. PubMed ID: 22490758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
    Grace RF; Bennett CM; Ritchey AK; Jeng M; Thornburg CD; Lambert MP; Neier M; Recht M; Kumar M; Blanchette V; Klaassen RJ; Buchanan GR; Kurth MH; Nugent DJ; Thompson AA; Stine K; Kalish LA; Neufeld EJ
    Pediatr Blood Cancer; 2012 Feb; 58(2):221-5. PubMed ID: 21674758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study.
    Kularatne SA; Walathara C; Mahindawansa SI; Wijesinghe S; Pathirage MM; Kumarasiri PV; Dissanayake AM
    Postgrad Med J; 2009 Oct; 85(1008):525-9. PubMed ID: 19789191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical comparative study on treatment of severe newly diagnosed immune thrombocytopenia by recombinant human thrombopoietin combined with glucocorticoid].
    Gu SY; Zhuang JL; Zou SH; Li F; Wang ZM; Cheng YF; Wang WG; Cheng ZX; Yuan L; Cheng LY; Wei Z
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):883-6. PubMed ID: 24171964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ghanima W; Khelif A; Waage A; Michel M; Tjønnfjord GE; Romdhan NB; Kahrs J; Darne B; Holme PA;
    Lancet; 2015 Apr; 385(9978):1653-61. PubMed ID: 25662413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients].
    Qin P; Wei Y; Hou M; Zhao C; Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):103-6. PubMed ID: 25778883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
    Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study.
    Chen H; Zheng W; Su J; Xu D; Wang Q; Leng X; Zhang W; Li M; Tang F; Zhang X; Zeng X; Zhao Y; Zhang F
    Rheumatology (Oxford); 2011 Sep; 50(9):1640-4. PubMed ID: 21571767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
    Zhu YC; Wang W; Zhou YH; Wang XM; Wang X; Wang YL; Sun GZ; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rituximab and Dexamethasone Combined with Cyclophosphamide for Treatment of Relapsed and Refractory Immune Thrombocytopenia].
    Han XD; Zhou J; Yu FK; Fang BJ; Zhang YL; Wei XD; Song YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):162-6. PubMed ID: 26913414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.